Institutional Ownership Revance Therapeutics, Inc. (RVNC)
This table provides information about the institutional ownership of Revance Therapeutics, Inc. (RVNC). We have compiled data on the 234 institutions that hold shares in the stock, with a total of 82.8 Million shares, which have been reported (via 13F filing form) to have a value of $213 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Farther Finance Advisors, LLC
San Francisco, CA |
Oct 28, 2024 Q3 2024 |
80
shares
|
$205
0.0% of portfolio
|
Q3 2024
Reduced 20.0%
|
|
|
Private Capital Group, LLC
|
Jul 28, 2022 Q2 2022 |
72
shares
|
$185
0.0% of portfolio
|
Q1 2022
Reduced 23.4%
|
|
|
Central Trust CO
Jefferson City, MO |
Oct 22, 2024 Q3 2024 |
50
shares
|
$128
0.0% of portfolio
|
Q3 2022
New holding
|
|
|
Bergan Kdv Wealth Management, LLC
|
Jul 24, 2023 Q2 2023 |
38
shares
|
$97
0.0% of portfolio
|
Q3 2022
New holding
|
|
|
Covestor LTD
Boston, MA |
Nov 01, 2024 Q3 2024 |
24
shares
|
$61
0.0% of portfolio
|
Q3 2024
Reduced 7.69%
|
|
|
Elequin Capital LP
New York, NY |
Nov 14, 2024 Q3 2024 |
17
shares
|
$43
0.0% of portfolio
|
Q3 2024
New holding
|
|
|
Federated Hermes, Inc.
Pittsburgh, PA |
Nov 13, 2024 Q3 2024 |
9
shares
|
$23
0.0% of portfolio
|
Q3 2024
Reduced 100.0%
|
|
|
Steward Financial Group LLC
|
Oct 20, 2023 Q3 2023 |
4
shares
|
$10
0.0% of portfolio
|
Q3 2023
New holding
|